BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/9/2023 11:18:42 AM | Browse: 187 | Download: 486
 |
Received |
|
2023-06-09 11:10 |
|
Peer-Review Started |
|
2023-06-09 11:13 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-07-18 07:58 |
|
Revised |
|
2023-07-31 22:02 |
|
Second Decision |
|
2023-08-21 00:23 |
|
Accepted by Journal Editor-in-Chief |
|
2023-08-21 13:15 |
|
Accepted by Executive Editor-in-Chief |
|
2023-08-28 16:48 |
|
Articles in Press |
|
2023-08-28 16:48 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-09-07 07:30 |
|
Publish the Manuscript Online |
|
2023-10-09 11:18 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Gut microbiome supplementation as therapy for metabolic syndrome
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mc Anto Antony, Aniqa Chowdhury, Dinesh Edem, Rishi Raj, Priyanshu Nain, Mansi Joglekar, Vipin Verma and Ravi Kant |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mc Anto Antony, MD, Staff Physician, Department of Endocrinology, Diabetes and Metabolism, Medical University Of South Carolina/AnMed Campus, 2000 E Greenville St Suite 3100, Anderson, SC 29621, United States. drmcanto@gmail.com |
| Key Words |
Gut dysbiosis; Metabolic syndrome; Diabetes mellitus; Prebiotics; Probiotics; Postbiotics |
| Core Tip |
Gut microbiome dysbiosis is related to chronic inflammation, insulin resistance, metabolic syndrome, cardiovascular diseases (CVD), and obesity. It is well known that obesity, type 2 diabetes mellitus and CVD are caused or worsened by multiple factors like genetic predisposition, environmental factors, unhealthy high calorie diets, and sedentary lifestyle. However, recent evidence from human and mouse models suggest that the gut microbiome is also an active player in modulation of these metabolic diseases. Hence it is important to review the role of microbiome supplementation that has been shown to improve the gut microbiome in patients with metabolic syndrome. |
| Publish Date |
2023-10-09 11:18 |
| Citation |
Antony MA, Chowdhury A, Edem D, Raj R, Nain P, Joglekar M, Verma V, Kant R. Gut microbiome supplementation as therapy for metabolic syndrome. World J Diabetes 2023; 14(10): 1502-1513 |
| URL |
https://www.wjgnet.com/1948-9358/full/v14/i10/1502.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v14.i10.1502 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
